These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8028472)

  • 1. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.
    Pharoah PD; Hollingworth W
    BMJ; 1996 Jun; 312(7044):1443-8. PubMed ID: 8664620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral Theories That Have Influenced the Way Health State Preferences Are Elicited and Interpreted: A Bibliometric Mapping Analysis of the Time Trade-Off Method With VOSviewer Visualization.
    Henstock L; Wong R; Tsuchiya A; Spencer A
    Front Health Serv; 2022; 2():848087. PubMed ID: 36925791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Theory and Medical Assistance in Dying.
    Redelmeier DA; Detsky AS
    Appl Health Econ Health Policy; 2021 Jan; 19(1):5-8. PubMed ID: 32372250
    [No Abstract]   [Full Text] [Related]  

  • 4. Parent Preferences for Health Outcomes Associated with Autism Spectrum Disorders.
    Lavelle TA; Weinstein MC; Newhouse JP; Munir K; Kuhlthau KA; Prosser LA
    Pharmacoeconomics; 2019 Apr; 37(4):541-551. PubMed ID: 30895565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year.
    Attema AE; Krol M; van Exel J; Brouwer WBF
    Eur J Health Econ; 2018 Mar; 19(2):277-291. PubMed ID: 28275878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A generalized measurement model to quantify health: the multi-attribute preference response model.
    Krabbe PF
    PLoS One; 2013; 8(11):e79494. PubMed ID: 24278141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should the arteriovenous fistula be created before starting dialysis?: a decision analytic approach.
    Hiremath S; Knoll G; Weinstein MC
    PLoS One; 2011; 6(12):e28453. PubMed ID: 22163305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for measuring temporary health States for cost-utility analyses.
    Wright DR; Wittenberg E; Swan JS; Miksad RA; Prosser LA
    Pharmacoeconomics; 2009; 27(9):713-23. PubMed ID: 19757865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and preferences for current health.
    King JT; Tsevat J; Roberts MS
    Health Qual Life Outcomes; 2009 Jan; 7():1. PubMed ID: 19134191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.
    Prosser LA; Hammitt JK; Keren R
    Pharmacoeconomics; 2007; 25(9):713-26. PubMed ID: 17803331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost.
    Yang BH; Bray FI; Parkin DM; Sellors JW; Zhang ZF
    Int J Cancer; 2004 Apr; 109(3):418-24. PubMed ID: 14961581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On individual preferences and aggregation in economic evaluation in healthcare.
    Liljas B; Lindgren B
    Pharmacoeconomics; 2001; 19(4):323-35. PubMed ID: 11383750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the psychometric properties of preference-based and nonpreference-based health-related quality of life in coronary heart disease. Canadian Collaborative Cardiac Assessment Group.
    Lalonde L; Clarke AE; Joseph L; Mackenzie T; Grover SA
    Qual Life Res; 1999 Aug; 8(5):399-409. PubMed ID: 10474281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation in healthcare. A brief history and future directions.
    Blumenschein K; Johannesson M
    Pharmacoeconomics; 1996 Aug; 10(2):114-22. PubMed ID: 10163414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A note on QALYs, time tradeoff, and discounting.
    Johannesson M; Pliskin JS; Weinstein MC
    Med Decis Making; 1994; 14(2):188-93. PubMed ID: 8028472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double discounting of QALYs.
    MacKeigan LD; Gafni A; O'Brien BJ
    Health Econ; 2003 Feb; 12(2):165-9. PubMed ID: 12563665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ranking properties of healthy-years equivalents and quality-adjusted life-years under certainty and uncertainty.
    Johannesson M
    Int J Technol Assess Health Care; 1995; 11(1):40-8. PubMed ID: 7706013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QALYs, HYEs and individual preferences--a graphical illustration.
    Johannesson M
    Soc Sci Med; 1994 Dec; 39(12):1623-32. PubMed ID: 7846559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [QALYS or not QALYS: that is the question?].
    Moatti JP; Auquier P; Le Coroller AG; Macquart-Moulin G
    Rev Epidemiol Sante Publique; 1995 Dec; 43(6):573-83. PubMed ID: 8552855
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.